Clinical Trial

Unravelling the Measles Paradox in Children

Study acronym: MISIA-k
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Measles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced immune suppression can last several years, whereas measles lymphopenia is usually resolved within two weeks. At the same time, measles induces lifelong immunity. This apparent contradiction, known as the 'measles paradox', was partially solved when investigators demonstrated that MeV infects and depletes pre-existing memory cells, thereby causing 'immune amnesia'. This model is supported by observations in animal models and clinical studies, but several questions remain to be addressed, like the duration of measles-induced amnesia and changes in the immune repertoire after measles. to address the immunological questions regarding MeV infection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-04; most recent amendment 2025-11-25.
Trial Details
NCT Number NCT06923631
Lead Sponsor Erasmus Medical Center
Conditions MEASLES DISEASE
Enrollment 100 participants
Start Date 2026-01-03
Primary Completion 2029-04-01 (estimated)
Study Completion 2029-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-26